Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Regeneron (REGN) and Intuitive Surgical (ISRG)
TipRanksMar 26 16:51
United Therapeutics Analyst Ratings
BenzingaMar 7 20:25
HC Wainwright & Co. Reiterates Buy on United Therapeutics, Maintains $300 Price Target
BenzingaFeb 22 19:48
United Therapeutics Analyst Ratings
BenzingaFeb 22 19:46
United Therapeutics Analyst Ratings
BenzingaFeb 12 18:14
United Therapeutics Analyst Ratings
BenzingaFeb 5 20:13
Morgan Stanley Maintains Overweight on United Therapeutics, Lowers Price Target to $314
BenzingaNov 3, 2023 03:19
United Therapeutics Analyst Ratings
BenzingaNov 3, 2023 03:19
United Therapeutics Analyst Ratings
BenzingaNov 2, 2023 21:13
United Therapeutics (UTHR) Receives a Buy From Wedbush
TipRanksAug 18, 2023 22:35
Ladenburg Thalmann Maintains Buy on United Therapeutics, Raises Price Target to $268
BenzingaAug 3, 2023 21:28
Wedbush Lifts United Therapeutics' Price Target to $307 From $305 After 'Strong' Q2 Results, Keeps Outperform Rating
MT NewswiresAug 3, 2023 19:04
United Therapeutics Analyst Ratings
BenzingaAug 3, 2023 18:27
The Latest Analyst Ratings for United Therapeutics
BenzingaMay 5, 2023 02:05
Ladenburg Thalmann Adjusts Price Target on United Therapeutics to $256 From $285, Maintains Buy Rating
MT NewswiresMay 4, 2023 22:18
Ladenburg Thalmann Maintains Buy on United Therapeutics, Lowers Price Target to $256
BenzingaMay 4, 2023 19:20
H.C. Wainwright Sticks to Its Buy Rating for United Therapeutics (UTHR)
TipRanksMay 4, 2023 18:31
Argus Research Maintains Buy on United Therapeutics, Lowers Price Target to $280
BenzingaApr 21, 2023 21:26
UBS Trims Price Target on United Therapeutics to $310 From $330, Keeps Buy Rating
MT NewswiresApr 10, 2023 22:33
Morgan Stanley Maintains Overweight on United Therapeutics, Lowers Price Target to $316
BenzingaApr 10, 2023 22:30
No Data
No Data